Global Human Serum Albumin and Globulin Market Growth (Status and Outlook) 2026-2032
The global Human Serum Albumin and Globulin market size is predicted to grow from US$ 6848 million in 2025 to US$ 10428 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.
Human serum albumin and globulin are the two major classes of proteins found in human blood plasma. Albumin is the most abundant plasma protein, primarily responsible for maintaining colloidal osmotic pressure, transporting hormones, fatty acids, and drugs, and contributing to overall blood volume regulation. Globulins are a diverse group of proteins that include immunoglobulins (antibodies), transport proteins, and enzymes, playing key roles in immune response, nutrient transport, and various biochemical processes. The balance between albumin and globulin is an important indicator of health, and abnormal levels can signify liver disease, kidney disorders, infections, or immune system dysfunction.
United States market for Human Serum Albumin and Globulin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Human Serum Albumin and Globulin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Human Serum Albumin and Globulin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Human Serum Albumin and Globulin players cover Grifols, CSL, Takeda, Octapharma, CBPO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Human Serum Albumin and Globulin Industry Forecast? looks at past sales and reviews total world Human Serum Albumin and Globulin sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Serum Albumin and Globulin sales for 2026 through 2032. With Human Serum Albumin and Globulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Serum Albumin and Globulin industry.
This Insight Report provides a comprehensive analysis of the global Human Serum Albumin and Globulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Serum Albumin and Globulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Human Serum Albumin and Globulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Serum Albumin and Globulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Serum Albumin and Globulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Serum Albumin and Globulin market by product type, application, key players and key regions and countries.
Segmentation by Type:
Human serum albumin and globulin are the two major classes of proteins found in human blood plasma. Albumin is the most abundant plasma protein, primarily responsible for maintaining colloidal osmotic pressure, transporting hormones, fatty acids, and drugs, and contributing to overall blood volume regulation. Globulins are a diverse group of proteins that include immunoglobulins (antibodies), transport proteins, and enzymes, playing key roles in immune response, nutrient transport, and various biochemical processes. The balance between albumin and globulin is an important indicator of health, and abnormal levels can signify liver disease, kidney disorders, infections, or immune system dysfunction.
United States market for Human Serum Albumin and Globulin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Human Serum Albumin and Globulin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Human Serum Albumin and Globulin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Human Serum Albumin and Globulin players cover Grifols, CSL, Takeda, Octapharma, CBPO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Human Serum Albumin and Globulin Industry Forecast? looks at past sales and reviews total world Human Serum Albumin and Globulin sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Serum Albumin and Globulin sales for 2026 through 2032. With Human Serum Albumin and Globulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Serum Albumin and Globulin industry.
This Insight Report provides a comprehensive analysis of the global Human Serum Albumin and Globulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Serum Albumin and Globulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Human Serum Albumin and Globulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Serum Albumin and Globulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Serum Albumin and Globulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Serum Albumin and Globulin market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Human Serum Albumin
- Human Serum Globulin
- Therapeutics
- Excipient
- Other
- Therapeutics
- Excipient
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Grifols
- CSL
- Takeda
- Octapharma
- CBPO
- Hualan Bio
- Kedrion
- Shanghai RAAS
- LFB Group
- Weiguang Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
%%
